Nebula Research & Development LLC Syndax Pharmaceuticals Inc Transaction History
Nebula Research & Development LLC
- $1.08 Trillion
- Q1 2025
A detailed history of Nebula Research & Development LLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Nebula Research & Development LLC holds 72,558 shares of SNDX stock, worth $653,022. This represents 0.08% of its overall portfolio holdings.
Number of Shares
72,558
Previous 76,914
5.66%
Holding current value
$653,022
Previous $1.02 Billion
12.34%
% of portfolio
0.08%
Previous 0.12%
Shares
3 transactions
Others Institutions Holding SNDX
# of Institutions
240Shares Held
101MCall Options Held
1.36MPut Options Held
618K-
Kynam Capital Management, LP Princeton, NJ8.52MShares$76.7 Million8.82% of portfolio
-
Black Rock Inc. New York, NY7.91MShares$71.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.87MShares$43.8 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.21MShares$37.9 Million5.73% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.01MShares$36.1 Million0.12% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $509M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...